Response Signature to the CD95-Ligand Inhibitor Asunercept...

Leukemia Research 2017 / 04 Vol. 55

Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl

Luft, T., Radujkovic, A., Nowak, D., Fricke, H., Kunz, C., Hofmann, W.K., Nolte, F., Dreger, P., Boch, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
55
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(17)30316-8
Date:
April, 2017
File:
PDF, 101 KB
english, 2017
Conversion to is in progress
Conversion to is failed